SAN DIEGO, (June 17, 2020, Globe Newswire) — Cellics Therapeutics, Inc. (Cellics) announced today that results of the study that evaluates the potential benefits of macrophage and pulmonary epithelial nanosponges in neutralizing SARS-CoV-2 infectivity have…
Our Mission
Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines. We strive to develop more effective and safer therapeutics and vaccines for diseases and unmet medical needs.